Caricamento...
OP15. Enhancement of Myeloid Dendritic Cells through MAPK p38 inhibition Promotes T cell Proliferation and Restores Adaptive Immunity in GBM Patients
INTRODUCTION: Immunotherapy is an emerging backbone to oncology treatment in a number of cancers, mainly due to the advent of checkpoint blockade therapy. In Glioblastoma (GBM) immunotherapies such as peptide vaccines and laboratory generated monocyte-derived dendritic cells (moDC) are demonstrating...
Salvato in:
| Pubblicato in: | Neuro Oncol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5358585/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now292.014 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|